There is no substitute for proven expertise when it comes to international law. That’s why leading media around the world so often turn to Harris Bricken for our insight.
“If you’re in the hemp derivative business, trust the DEA at your own peril. While it is true that the 2018 Farm Bill did legalize hemp, hemp derivatives, hemp extracts, and cannabinoids in hemp, it did not explicitly cover hemp processing,” business attorney and cannabis advocate Daniel Shortt wrote on Harris Bricken‘s Canna Law Blog.
ReadFormer US diplomat Fred Rocafort, who now works at the international law firm Harris Bricken, says prison and forced labor have infected China’s supply chain. Fred has worked as a commercial lawyer in China for over 10 years. During this time, he has conducted more than 100 audits on defense of foreign brands’ intellectual property and forced labor.
ReadBut according to Daniel Shortt, a business attorney at Harris Bricken who works extensively with entrepreneurs in the cannabis industry, there’s some devil in the detail.
In a nutshell, Mr. Shortt said the rule would make in-process hemp extract that may temporarily contain a higher percentage of delta-9 THC a schedule I substance, regardless of whether that THC is diluted or removed in an end product.
ReadDaniel Shortt, a business attorney at the cannabis-focused law firm Harris Bricken, shares concerns about DEA’s IFR. He told Marijuana Moment in a phone interview that he doesn’t “give the DEA the benefit of the doubt because they have just historically fought against any shrinking of their jurisdiction.”
Readis an attorney at Harris Bricken. This article was originally published on the Canna Law Blog and is reposted with permission.
Read“The way that this rule is written, there is a serious problem for processors who may have a delta-9 THC byproduct that never was intended for sale,” Shortt tells Hemp Grower. “With the way these rules are written, I think those people are now at risk.”
Read
